|
ADHD Headlines
Developmental Coordination Disorder Often Misdiagnosed As ADHD
Children showing difficulty carrying out routine actions, such as getting dressed, playing with particular types of games, drawing, copying from the board in school and even typing at the computer, could be suffering from developmental coordination disorder (DCD), and not necessarily from ADHD or other more familiar disorders, points out Prof...
Mon, 13 Feb 2012 00:00:00 PST - Source:MedNewsToday
Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA
In the U.S., in 2007, the prescription medication Vyvanse was introduced for the treatment of ADHD in children aged 6 to 12 years old by the US Food and Drug Administration (FDA). The following year the medication was approved to treat ADHD in adults, and approved in 2010 to treat adolescents aged 13 to 17 with ADHD...
Fri, 10 Feb 2012 10:00:00 PST - Source:MedNewsToday
No Association Between Stimulant Treatment For ADHD And Increased Risk Of Cardiac Events In Youth
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure...
Fri, 10 Feb 2012 01:00:00 PST - Source:MedNewsToday
How Stimulants Work To Control Hyperactivity
It has long been known that psychostimulant drugs have the paradoxical effect of reducing hyperactivity. [Psychostimulant drugs include methylphenidate - known by the trade names Ritalin, Concerta, and Methylin - and methamphetamine]. Since the mid-1950s, millions of children and adults have been prescribed stimulant medications to control attention deficit hyperactivity disorder (ADHD)...
Fri, 10 Feb 2012 00:00:00 PST - Source:MedNewsToday
Multiple Exposure To Anesthesia Increases Risk Of ADHD In Young Children
Mayo Clinic researchers have found that multiple exposures to anesthesia at a young age are associated with higher rates of attention-deficit/hyperactivity disorder (ADHD). Children exposed to two or more anesthetics before age 3 had more than double the incidence of ADHD than children who had no exposure, says David Warner, M.D...
Mon, 06 Feb 2012 00:00:00 PST - Source:MedNewsToday
Anesthesia Exposure Linked To ADHD In Children
A study by researchers at Mayo Clinic, Rochester Minn., and published in Mayo Clinic Proceedings, reveals that children who have been under anesthesia many times when they are young have a greater risk of developing attention-deficit/hyperactivity disorder (ADHD). According to David Warner, M...
Fri, 03 Feb 2012 00:00:00 PST - Source:MedNewsToday
Improved Behavior For Children With ADHD Taking Part In Physical Activity Program
While children who suffer from attention-deficit hyperactivity disorder (ADHD) struggle with hyperactive-impulses and have trouble maintaining attention, a recent study found that a structured physical activity program may help to improve their muscular capacities, motor skills, behavior assessments, and the ability to process information...
Thu, 19 Jan 2012 00:00:00 PST - Source:MedNewsToday
Positive Response For Children With ADHD In Study Of Combination Therapy
While pharmacologic agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity disorder (ADHD), some children have suboptimal response to a single pharmacologic agent. A recent study by Dr. Timothy E...
Wed, 11 Jan 2012 01:00:00 PST - Source:MedNewsToday
Gestational Diabetes Linked To ADHD Risk In Offspring
According to a report Online First by Archives of Pediatrics & Adolescent Medicine, babies who are born to mothers with diabetes during their pregnancy and/or living in low income households, have a higher risk of subsequently developing ADHD during childhood...
Wed, 04 Jan 2012 11:00:00 PST - Source:MedNewsToday
Adderall Shortage Set To Continue
Adderall is a stimulant used to treat ADHD, but it's also a controlled substance due to the addictive qualities of the drug. The DEA (Drug Enforcement Agency) monitors and controls how much of the base ingredients to manufacture the drug can be distributed to pharmaceutical companies...
Tue, 03 Jan 2012 11:00:00 PST - Source:MedNewsToday
Risk Of ADHD In Children Increased By Gestational Diabetes And Low Socioeconomic Status
In the first study of its kind, researchers at Queens College and Mount Sinai School of Medicine have found that low socioeconomic status (SES) and maternal gestational diabetes together may cause a 14-fold increased risk of attention deficit hyperactivity disorder (ADHD) in six year olds...
Tue, 03 Jan 2012 01:00:00 PST - Source:MedNewsToday
ADHD Drugs Do Not Raise Stroke, Heart Attack Or Sudden Cardiac Death Risk
Young and middle-aged adults who are prescribed ADHD (attention deficit/hyperactivity disorder) drugs do not have a higher chance of developing serious cardiovascular events, such as sudden cardiac death, heart attack or stroke, researchers from Kaiser Permanente Northern California, Oakland, reported in JAMA (Journal of the American Medical Association)...
Tue, 13 Dec 2011 00:00:00 PST - Source:MedNewsToday
How Our Brains Keep Us Focused
In a new study to appear in Neuron, scientists at the RIKEN Brain Science Institute (BSI) have uncovered mechanisms that help our brain to focus by efficiently routing only relevant information to perceptual brain regions...
Fri, 09 Dec 2011 00:00:00 PST - Source:MedNewsToday
Defects In Brain Signaling Pathways Suggested By New Gene Study Of ADHD
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants - potentially, half a million U.S. children...
Tue, 06 Dec 2011 00:00:00 PST - Source:MedNewsToday
ADHD - Four Genes Linked To The Disorder
Four gene variants, all members of the glutamate receptor gene family, appear to be involved in vital brain signaling pathways in a sub-set of children with ADHD (attention deficit hyperactivity disorder), researchers from the Center for Applied Genomics at The Children's Hospital of Philadelphia reported in the journal Nature Genetics...
Tue, 06 Dec 2011 00:00:00 PST - Source:MedNewsToday
fMRI Reveals Functional Brain Pathways Disrupted In Children With ADHD
Using functional magnetic resonance imaging (fMRI), researchers have identified abnormalities in the brains of children with attention deficit/hyperactivity disorder (ADHD) that may serve as a biomarker for the disorder, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA)...
Mon, 28 Nov 2011 00:00:00 PST - Source:MedNewsToday
Women Need ADHD Meds As Well ...
ADHD is usually thought of as a predominantly male problem, but a new report from Medco Health Solutions shows the number of women taking medication for ADHD is rising rapidly. Researchers studied trends in the use of mental health medications among about 2.5 million insured Americans and found that the number of women aged 20 to 44 on ADHD medicines shot up 250% from 2001 to 2010...
Wed, 16 Nov 2011 18:00:00 PST - Source:MedNewsToday
Performance Linked To Changes In Human Brain Structure Function: Findings Explore Complexities Of How The Brain Learns, Stores, And Recalls Info
New research just released provides insight into one of neuroscience's most intriguing mysteries: how the human brain learns and remembers...
Wed, 16 Nov 2011 00:00:00 PST - Source:MedNewsToday
Brain Chemistry Directly Altered By Parasite
A research group from the University of Leeds has shown that infection by the brain parasite Toxoplasma gondii, found in 10-20 per cent of the UK's population, directly affects the production of dopamine, a key chemical messenger in the brain. Their findings are the first to demonstrate that a parasite found in the brain of mammals can affect dopamine levels...
Mon, 07 Nov 2011 01:00:00 PST - Source:MedNewsToday
FDA Says ADHD Medications Are OK
Good news for parents with over active children, the FDA confirmed that a study, which included more than one million children and young adults (2-24 years), showed that cardiovascular problems are not associated with ADHD medications. Looking at a total of more than 2...
Tue, 01 Nov 2011 13:00:00 PST - Source:MedNewsToday
Parent Training Is Low Risk And Effective For Treating Preschoolers With ADHD
A new report from the U.S...
Sat, 29 Oct 2011 00:00:00 PST - Source:MedNewsToday
Training Parents Effective For Treating Young Children With ADHD
Formal training in parenting strategies is a low-risk, effective method for improving behavior in preschool-age children at risk for developing attention deficit hyperactivity disorder (ADHD), while there is less evidence supporting the use of medications for children younger than 6 years old, according to a new report from the U.S...
Wed, 26 Oct 2011 01:00:00 PST - Source:MedNewsToday
ADHD Drug More Effective In Children With Certain Dopamine System Gene Variants
Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate the guesswork from prescribing effective medications for children with ADHD...
Mon, 24 Oct 2011 00:00:00 PST - Source:MedNewsToday
Children's ADHD Drug Response Depends On Specific Dopamine Gene Variants
According to a new study published in the Journal of the American Academy of Child and Adolescent Psychiatry, children with certain dopamine system gene variants have an improved response to methylphenidate (Ritalin) - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder (ADHD)...
Sun, 23 Oct 2011 17:00:00 PST - Source:MedNewsToday
ADHD Drug Lisdexamfetamine Dimesylate (LDX) Shows Promise For Children And Adolescents
Shire plc presented positive top-level results of their first European phase III study of lisdexamfetamine dimesylate (LDX), designed for children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder (ADHD). LDX is administered once daily and is the first chemically formulated long-acting, prodrug of dexamfetamine for treating ADHD...
Sun, 23 Oct 2011 10:00:00 PST - Source:MedNewsToday
|
|
|
